We next investigated the effect, if any, of PLD inhibitors on the tumor microenvironment with a specific focus on certain components of the circulatory/inflammatory system that are affected by PLD signaling, such as macrophages or neutrophils, both of which have been implicated in poor prognosis of breast cancer studies [3,4]. Here, GPLD1 is linked to neoplasm.